ANTEOTECH LTD — Director's Dealing 2016

Jul 3, 2016

4[th] July 2016

==> picture [276 x 74] intentionally omitted <==

AMENDED APPENDIX 3Y

For Immediate Release:

==> picture [454 x 54] intentionally omitted <==

==> picture [589 x 113] intentionally omitted <==

Appendix 3Y

Rule 3.19A.2

==> picture [224 x 57] intentionally omitted <==

Information or documents not available now must be given to ASX as soon as available. Information and

Anteo Diagnostics Limited

75 070 028 625

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Mr Richard Martin 5.12.2014

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In uld be disclosed in this part.

Direct n/a Note: Provide details of the circumstances giving rise to the relevant interest. 11.01.2016 1,400,000 fully paid shares 6,000,000 unlisted Options ex price $.20, Expiry 10.11.2018 fully paid shares 4,000,000 Nil $300,000 Note: If consideration is non-cash, provide details and estimated valuation

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y

6,000,000 unlisted Options ex price $.20, Expiry 10.11.2018 5,400,000 Fully Paid Shares Participation in Rights Issue Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Note: should be disclosed in this part.

n/a n/a n/a n/a n/a Note: Details are only required for a contract in relation to which the interest has changed n/a n/a n/a Note: If consideration is non-cash, provide details and an estimated valuation n/a

No n/a n/a

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011